Stockholders' Equity - Warrant activity (Details) - Warrant - USD ($) $ / shares in Units, $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2022 |
Dec. 31, 2021 |
Dec. 31, 2020 |
|
| Stockholders' Equity | |||
| Unvested balance at beginning | 997 | 1,056 | |
| Warrants, Exercise | (1,029,200) | (59) | |
| Warrants, Granted | 5,166,119 | ||
| Unvested balance at end | 4,137,916 | 997 | |
| Weighted Average Exercise Price, Outstanding at beginning | $ 9.9807 | $ 9.4231 | |
| Weighted Average Exercise Price, Outstanding at end | 3.3016 | 9.9807 | |
| Weighted Average Grant Date Fair Value, Granted | 2.6713 | ||
| Weighted Average Exercise Price, Exercised | $ 0.1441 | $ 0.0015 | |
| Aggregate Intrinsic Value | $ 1 | $ 11 | $ 84 |
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options that exercised during the reporting period. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which equity instruments holders acquired shares when converting their equity instruments into shares. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the equity-based plan. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
| X | ||||||||||
- Details
|